adenine has been researched along with Atrophy in 9 studies
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Mendieta-Condado, E | 1 |
| Villaseñor-Tapia, EC | 1 |
| Gálvez-Gastelum, FJ | 1 |
| Yáñez-Sánchez, I | 1 |
| Pizano-Martínez, O | 1 |
| Canales-Aguirre, A | 1 |
| Márquez-Aguirre, AL | 1 |
| Virgolini, MJ | 1 |
| Feliziani, C | 1 |
| Cambiasso, MJ | 1 |
| Lopez, PH | 1 |
| Bollo, M | 1 |
| Belghasem, ME | 1 |
| A'amar, O | 1 |
| Roth, D | 1 |
| Walker, J | 1 |
| Arinze, N | 1 |
| Richards, SM | 1 |
| Francis, JM | 1 |
| Salant, DJ | 1 |
| Chitalia, VC | 1 |
| Bigio, IJ | 1 |
| Radford, H | 1 |
| Moreno, JA | 1 |
| Verity, N | 1 |
| Halliday, M | 1 |
| Mallucci, GR | 1 |
| UEBELIN, R | 1 |
| Viganò, A | 1 |
| Brambilla, P | 1 |
| Cafarelli, L | 1 |
| Giacomet, V | 1 |
| Borgonovo, S | 1 |
| Zamproni, I | 1 |
| Zuccotti, G | 1 |
| Mora, S | 1 |
| Jönsson, E | 1 |
| Brené, S | 1 |
| Lindblad, K | 1 |
| Sharara, S | 1 |
| Sedvall, G | 1 |
| Schalling, M | 1 |
| Latkany, P | 1 |
| Ciulla, TA | 1 |
| Cacchillo, PF | 1 |
| Malkoff, MD | 1 |
| Yokozawa, T | 1 |
| Zheng, PD | 1 |
| Oura, H | 1 |
| Koizumi, F | 1 |
1 trial available for adenine and Atrophy
| Article | Year |
|---|---|
Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz.
Topics: Absorptiometry, Photon; Adenine; Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highl | 2007 |
8 other studies available for adenine and Atrophy
| Article | Year |
|---|---|
Effects of Etanercept on TNF-
Topics: Adenine; Animals; Atrophy; Etanercept; Fibrosis; Rats; Renal Insufficiency, Chronic; Tumor Necrosis | 2022 |
Neurite atrophy and apoptosis mediated by PERK signaling after accumulation of GM2-ganglioside.
Topics: Adenine; Animals; Apoptosis; Atrophy; Cell Line, Tumor; eIF-2 Kinase; Endoplasmic Reticulum; Endopla | 2019 |
Towards minimally-invasive, quantitative assessment of chronic kidney disease using optical spectroscopy.
Topics: Adenine; Animals; Atrophy; Blood Urea Nitrogen; Diet; Disease Models, Animal; Female; Fibrosis; Kidn | 2019 |
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia.
Topics: Adenine; Animals; Atrophy; Brain; Disease Models, Animal; eIF-2 Kinase; Female; Frontotemporal Demen | 2015 |
[Adenine inhibition of the lymphocytopenia and the atrophy of the thymus appearing after the administration of glucose].
Topics: Adenine; Atrophy; Disease; Glucose; Humans; Lymphocytes; Lymphopenia; Thymus Gland | 1953 |
Lack of expansion of cytosine adenine guanine trinucleotide repeat in the dentatorubral and pallidoluysian atrophy gene in Swedish schizophrenic patients.
Topics: Adenine; Alleles; Atrophy; Autoradiography; Chromosomes, Human, Pair 13; Cytosine; Dentate Gyrus; Gl | 1996 |
Mitochondrial maculopathy: geographic atrophy of the macula in the MELAS associated A to G 3243 mitochondrial DNA point mutation.
Topics: Adenine; Atrophy; Deafness; DNA, Mitochondrial; Electroretinography; Female; Guanine; Humans; Macula | 1999 |
Animal model of adenine-induced chronic renal failure in rats.
Topics: Adenine; Amino Acids; Animals; Atrophy; Creatinine; Disease Models, Animal; Fibrosis; Guanidines; Ho | 1986 |